404
+1-313-307-4176
sales@stratviewresearch.com
HPMC Capsules Market Report
HPMC Capsules Market Trends, Dynamics & Market Insights
The HPMC Capsules Market is estimated to grow from USD 357.2 million in 2020 to USD 600.4 million by 2026 at a healthy CAGR of 9.2% during the forecast period.
Wish to get a free sample? Register Here
The Hydroxypropyl methylcellulose (HPMC) capsules are also referred to as hypromellose. These are synthesized through the synthetic alteration of natural polymer cellulose and are considered safe for human consumption. The HPMC is primarily used as a substitute for hard shell gelatin capsules, as the HPMC capsules are manufactured using plant extracts.
Key players operating in the HPMC capsules market are-
The nutraceutical and pharmaceutical players have created a surging demand for the HPMC capsules in the past few years. This rising interest is in consideration with the vegetarian-based capsule properties to prevent manufacturing problems related to drug gelatin interactions and restriction in formulation with gelatin capsule, which boosts the product demand. Also, the manufacturing units are strongly focusing on producing halal and kosher certified products to strengthen opportunities of the growing demand from the Muslim regions around the world. Moreover, the rise in demand for innovated and developed products has leveraged the scope for the HPMC capsule market.
Based on type, the market has been bifurcated into with gelling aid and without gelling aid. The gelling aid segment accounted for a substantial market share in 2020. The gelling aid segment is further classified into gellan gum, carrageenan, and others. The gelling agent offers stable and robust performance. These are mainly suitable for moisture-sensitive product fills, which further bolster the segment growth in the coming years.
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure and favorable government initiatives. Moreover, rising innovations in technologically advanced products, immense per capita health expenditures, and strong investments in R&D for effective treatment alternatives, which further proliferate the regional growth.
The COVID-19 outbreak moderately affected the growth of the HPMC Capsules market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. Rising concern regarding animal protein amid the pandemic has resulted in a growing need for vegetarian-based HPMC capsules.
Here is the list of the group of customers that the HPMC capsules market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
The HPMC capsules market is expected to witness an impressive growth of 9.2% CAGR in the foreseeable future.
ACG Worldwide Pvt., Ltd. (India), BioCaps Enterprise (US), Bright Caps GmbH (Austria), Bright Pharmacaps Inc. (US), Capscanada Corporation (Canada), Capsugel, Inc., Excellent Health Prod-ucts Co., Ltd., Farmacapsulas S.A. (Colombia), Healthcaps India Limited (India), and Natural Cap-sules Ltd. (India) are among the key players in the HPMC capsules market.
The HPMC capsules market size is expected to reach USD 600.4 million in the foreseeable future.
The gelling aid segment accounted for the substantial share in the HPMC capsules market in 2020.
North America is expected to remain dominant in the HPMC capsules market in the next five years.
HPMC Capsules distributors, HPMC Capsules suppliers, HPMC Capsules manufacturers, Hospitals, Government bodies are the target audience in the HPMC capsules market.
WE ACCEPT
